Capital Research Global Investors Ideaya Biosciences, Inc. Transaction History
Capital Research Global Investors
- $463 Billion
- Q3 2024
A detailed history of Capital Research Global Investors transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Capital Research Global Investors holds 2,566,356 shares of IDYA stock, worth $64.9 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,566,356
Previous 2,164,551
18.56%
Holding current value
$64.9 Million
Previous $76 Million
6.98%
% of portfolio
0.02%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding IDYA
# of Institutions
215Shares Held
80.8MCall Options Held
69KPut Options Held
20K-
Black Rock Inc. New York, NY6.81MShares$172 Million0.01% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA5.21MShares$132 Million0.38% of portfolio
-
Janus Henderson Group PLC London, X05.16MShares$131 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.8MShares$121 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.02MShares$102 Million0.01% of portfolio
About IDEAYA Biosciences, Inc.
- Ticker IDYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,067,700
- Market Cap $1.22B
- Description
- IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...